Hooke Laboratories

Hooke Laboratories operates a dual business model, combining the sale of high-quality, pre-characterized research reagents (like its Hooke Kits™ for inducing CIA and EAE) with a full-service preclinical CRO focused on immunological and inflammatory disease models. The company serves a prestigious clientele, including top-tier pharmaceutical firms, biotechs, and academic institutions. Its core expertise lies in standardizing complex animal models to improve reproducibility and accelerate drug discovery in autoimmune, respiratory, and infectious disease research.

Standardization platform for preclinical rodent models of inflammation and autoimmunity, featuring pre-characterized antigen/adjuvant emulsion kits (Hooke Kits™) and deep expertise in disease model establishment, analysis, and histology services.

Hooke competes in the specialized preclinical CRO and research reagent market against giants like Charles River Laboratories and Labcorp, as well as numerous smaller, focused CROs. Its differentiation hinges on deep, standardized expertise in complex immunological models, particularly EAE and CIA, and its dual product/service model.